Jobbörse
Finde Jobs in deiner Nähe – ob vor Ort, hybrid oder remote.- Ähnliche Jobs zu: Scientist - Infectious Diseases - Oxford
Scientist - Infectious Diseases - Oxford
ImmunocoreGarsington
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreNuneham CourtenayScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreWheatleyScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreDentonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreNorthmoorScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreCharlton on OtmoorScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreStadhamptonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreGreat MiltonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreDraytonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreMertonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreGreat HaseleyScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreCombeScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreLittle WittenhamScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocorePiddingtonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreBlackthornScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreHarwellScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreNorth MoretonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreRamsdenScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreLauntonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreWallingfordScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreSteeple AstonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreBamptonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreMiddle AstonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreKingswoodScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreWoodhamScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio